BERLIN (AP) — Swiss-based pharmaceutical company Novartis says second-quarter net income dropped 32 percent over the same quarter last year, brought down primarily by poor performance from associated companies and negative effects of a strong U.S. dollar. [...] CEO Joseph Jimenez said Tuesday that the company had a strong quarter for innovation with the U.S.